Search Results - "Wen, Zonghua"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Rapid and label-free histological imaging of unprocessed surgical tissues via dark-field reflectance ultraviolet microscopy by Ye, Shiwei, Zou, Junjie, Huang, Chenming, Xiang, Feng, Wen, Zonghua, Wang, Nannan, Yu, Jia, He, Yuezhi, Liu, Peng, Mei, Xin, Li, Hui, Niu, Lili, Gong, Peng, Zheng, Wei

    Published in iScience (20-01-2023)
    “…Routine examination for intraoperative histopathologic assessment is lengthy and laborious. Here, we present the dark-field reflectance ultraviolet microscopy…”
    Get full text
    Journal Article
  2. 2

    Abnormal expression of p-ATM/CHK2 in nasal extranodal NK/T cell lymphoma, nasal type, is correlated with poor prognosis by Ye, Qiurong, Chen, Huiling, Wen, Zonghua, Guo, Wenwen, Huang, Yongta, Mo, Xianglan

    Published in Journal of clinical pathology (01-04-2021)
    “…The aim of this study is to investigate the expression profiles of cell cycle related proteins in nasal extranodal NK/T cell lymphoma, nasal type (ENKTCL). The…”
    Get more information
    Journal Article
  3. 3

    Effect of Bioactive Black Phosphorus Nanomaterials on Cancer-Associated Fibroblast Heterogeneity in Pancreatic Cancer by Qu, Jianhua, Yan, Zilong, Lei, Defeng, Zhong, Tongning, Fang, Chongzhou, Wen, Zonghua, Liu, Jikui, Lai, Zhengquan, Yu, Xue-Feng, Zheng, Biao, Geng, Shengyong

    Published in ACS nano (23-07-2024)
    “…Tumor-stromal interactions and stromal heterogeneity in the tumor microenvironment are critical factors that influence the progression, metastasis, and…”
    Get full text
    Journal Article
  4. 4

    GOLM1 promotes prostate cancer progression via interaction with PSMD1 and enhancing AR‐driven transcriptional activation by Yan, Guang, Zhu, Tianhang, Zhou, Jiawei, Li, Xia, Wen, Zonghua, Miuhuitijiang, Bahaerguli, Zhang, Zhiyong, Du, Yuejun, Li, Chengyao, Shi, Xiaojun, Tan, Wanlong

    Published in Journal of cellular and molecular medicine (01-10-2024)
    “…Aberrant transcriptional activation of the androgen receptor (AR) is a predominant cause of prostate cancer (PCa), including both in the initial and…”
    Get full text
    Journal Article
  5. 5

    Lenalidomideas a Second-line Therapy Achieves Long-term Remission in Elderly Patients with Relapsed/Refractory Multicentric Castleman's Disease:a Report of Two Cases and Literature Review by TANG Yangming, SHI Renzhou, LAN Mei, LI Xuejun, WEN Zonghua, LU Xiaochen

    Published in Zhongguo quanke yixue (01-01-2022)
    “…No standard therapy is recommended for elderly multicentric Castleman's disease (MCD) patients who failed to the first-line treatment or relapsed. Lenalidomide…”
    Get full text
    Journal Article
  6. 6